company background image

Nile for Pharmaceuticals and Chemical Industries CASE:NIPH Stock Report

Last Price


Market Cap







07 Dec, 2022


Company Financials
NIPH fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance4/6
Financial Health4/6

NIPH Stock Overview

The Nile Co. for Pharmaceuticals and Chemical Industries develops, produces, and sells pharmaceutical products primarily in the Middle East.

The Nile Co. for Pharmaceuticals and Chemical Industries Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Nile for Pharmaceuticals and Chemical Industries
Historical stock prices
Current Share Priceج.م34.42
52 Week Highج.م37.89
52 Week Lowج.م25.01
1 Month Change-3.07%
3 Month Change-3.07%
1 Year Change20.43%
3 Year Change55.82%
5 Year Change90.17%
Change since IPO130.49%

Recent News & Updates

Recent updates

Shareholder Returns

NIPHEG PharmaceuticalsEG Market

Return vs Industry: NIPH matched the EG Pharmaceuticals industry which returned 19.7% over the past year.

Return vs Market: NIPH exceeded the EG Market which returned 19.3% over the past year.

Price Volatility

Is NIPH's price volatile compared to industry and market?
NIPH volatility
NIPH Average Weekly Movement6.1%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement5.8%
10% most volatile stocks in EG Market9.0%
10% least volatile stocks in EG Market3.5%

Stable Share Price: NIPH is not significantly more volatile than the rest of EG stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: NIPH's weekly volatility (6%) has been stable over the past year.

About the Company

1962n/aHesham Abd Elsayed

The Nile Co. for Pharmaceuticals and Chemical Industries develops, produces, and sells pharmaceutical products primarily in the Middle East. The company offers prescription pharmaceutical products, including tablets, capsules, dry syrups, syrups and suspensions, ointments, gels and creams, suppositories, ampoules, drops, parenteral, sachets, biotechnological products, lyophilized products, sterile antibiotic vials, lotions, shampoos, and solutions. It also provides non-prescription pharmaceutical products, such as analgesic and anti-inflammatory, antihistaminic, anthelmintic, antibacterial, antifungal, cardiovascular disorders, central nervous system and antiparkinsonism drugs, oral cavity products, respiratory system disorders, urinary tract disorders, endocrine glands disorders, gastrointestinal tract disorders, muscle relaxants, topical otic and nasal preparations, topical ophthalmological preparations, dermatological preparations, women and men healthcare products, osteoporosis, pediatrics, cosmetics, antiseptics, and immunological products, as well as vitamins and minerals.

The Nile Co. for Pharmaceuticals and Chemical Industries Fundamentals Summary

How do Nile for Pharmaceuticals and Chemical Industries's earnings and revenue compare to its market cap?
NIPH fundamental statistics
Market Capج.م348.50m
Earnings (TTM)ج.م89.67m
Revenue (TTM)ج.م876.78m


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
NIPH income statement (TTM)
Cost of Revenueج.م654.44m
Gross Profitج.م222.34m
Other Expensesج.م132.67m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date


Earnings per share (EPS)8.86
Gross Margin25.36%
Net Profit Margin10.23%
Debt/Equity Ratio18.5%

How did NIPH perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio